NEWS 12 FEED & ADDITIVE MAGAZINE February 2023 Evonik, one of the world leaders in specialty chemicals, announced that it has invested €25 million in methionine intermediates production plant upgrade in Wesseling, Germany. The investment will safeguard long-term supply of MMP to European methionine production hub. MMP is integral in the production of MetAMINO® (DL-methionine) which is used in animal feed to improve the performance of livestock farming. The precursors of this essential amino acid have been produced in Wesseling for more than 50 years. Dr. Gaetano Blanda, head of Animal Nutrition business line, said: “With this investment, Evonik is strengthening the European methionine network to safeguard the long-term supply of MMP to our MetAMINO® production hub in Antwerp, Belgium. The move underscores our commitment to serving and expanding the global DL-methionine market and secures the best possible supply security for our customers.” The conversion and expansion of the plant in Wesseling has been made possible by the development of a new production process, that will allow to avoid the storage of chemical intermediates, such as acrolein, at the site. Commenting on the plant upgrade, Dr. Jan-Olaf Barth, head of the Essential Nutrition product line, said: “Evonik is known for its innovative approach and world-class technology, and in Wesseling we have now developed a process that increases efficiency and, with Responsible Care in mind, further enhances safety at the site.” Read more>> Evonik invests €25m in methionine intermediates production plant BioZyme® announced its new product AO-Biotics®, a line of fermentation products derived the company’s innovative fermentation of Aspergillus oryzae (AO) which promotes resilience. Thanks to AO-Biotics®‘s unique capacity to produce cell components and metabolites, it is ideal for producing innovative postbiotics. The first product addition to the AO-Biotics is Amaferm®. For the last 50-plus years, Amaferm has been the hallmark ingredient in BioZyme’s premier line of animal nutritional supplements and health products. It is a prebiotic research-proven to enhance digestibility. While research continues to expand on Amaferm, BioZyme is also on track to develop new products under the AO-Biotics brand. These will include both prebiotics and postbiotics. “We are very passionate about utilizing our expertise in AO fermentation to develop new products that address common challenges in animal agriculture globally,” said Lisa Norton, President and CEO. BioZyme, a member of the International Science Association for Probiotics and Prebiotics (ISAPP), has long manufactured and marketed prebiotics. However, inaugural sales of postbiotics are scheduled for the first quarter of 2023. Postbiotics are defined by ISAPP as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.” Read more>> BioZyme® launches new brand for fermentation products
RkJQdWJsaXNoZXIy MTUxNjkxNQ==